Rubicon Point Partners (RPP) has acquired the Shockwave Medical headquarters, a 201,078-square-foot, four-building R&D campus at 5353 Betsy Ross Dr. in Santa Clara, on behalf of Rubicon Point Fund II. Terms were not disclosed. The property is 100% NNN leased to Shockwave Medical, Inc., a medical device company and wholly owned subsidiary of Johnson & Johnson.
“This is the beginning of a billion-dollar investment strategy that we plan to deploy over the coming few years throughout the region,” said Ani Vartanian, co-founder and managing partner of Rubicon Point Partners. “This acquisition represents the quality and caliber of assets we will continue to target: mission-critical real estate leased to world-class tenants in the most dynamic markets on the West Coast.”
The acquisition reflects RPP’s strategy of targeting institutional-quality assets in supply-constrained, innovation-driven markets where long-term demand is anchored by technology and innovation. CBRE National Office Partners served as the exclusive advisor to RPP.
The post Rubicon Point Acquires Shockwave Medical Headquarters appeared first on Connect CRE.
